Trial Profile
A prospective, multicenter, randomised study comparing efficacy and safety of Mirodenalfil 50 mg once daily and 100 mg on-demand for erectile dysfunction in patients with radical prostatectomy due to prostate cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Jun 2017
Price :
$35
*
At a glance
- Drugs Mirodenafil (Primary)
- Indications Erectile dysfunction
- Focus Adverse reactions; Therapeutic Use
- 07 Jun 2017 New trial record
- 16 May 2017 Results presented at the 112th Annual Meeting of the American Urological Association